EFPIA To Further Tighten Ethical Guidelines Addressing Pharma's EU Marketing Practices
This article was originally published in The Pink Sheet Daily
Board proposes creation of a national ethics group in each of its 31 member countries to oversee pharma compliance.
You may also be interested in...
Whether prescribing physicians should reject the drug and medical device industry's financial support for their continuing medical education is shaping up as the next major fight in the ongoing war over conflicts of interest in medicine
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.